Clinical Trials Directory

Trials / Completed

CompletedNCT05378295

Personalized Fiber and Insulin Sensitivity

Personalized Microbial Substrates to Prevent Type 2 Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
30 Years – 70 Years
Healthy volunteers
Accepted

Summary

In this project the investigators intend to study the therapeutic potential of a personalized fibre mixture in individuals at high risk of developing T2DM, and aim to address the following key objectives: 1. To investigate whether a mixture of fermentable fibres, which differ in DP and side chains, will stimulate a broad range of SCFA-producing bacterial genera, resulting in enhanced chronic SCFA production throughout the whole colon with a large variation between individuals; 2. To unravel whether providing personalized fibre mixtures, selected based on the individuals' initial microbiota and capacity for SCFA production is crucial to successfully improve host insulin sensitivity and metabolic health

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFermentable oligosaccharideSupplementation period 12 weeks
DIETARY_SUPPLEMENTPersonalized fiber mixtureSupplementation period 12 weeks

Timeline

Start date
2021-11-05
Primary completion
2024-04-22
Completion
2024-04-22
First posted
2022-05-18
Last updated
2024-04-23

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05378295. Inclusion in this directory is not an endorsement.